APA
ALXN

American Portfolios Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

American Portfolios Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50
Closed -$9.19K – 3577
2021
Q2 		$9.19K Sell
50
-1,405
-97% -$241K ﹤0.01% 2565
2021
Q1 		$222K Buy
1,455
+396
+37% +$61.3K 0.01% 972
2020
Q4 		$165K Sell
1,059
-70
-6% -$8.99K 0.01% 961
2020
Q3 		$129K Buy
1,129
+155
+16% +$16.7K 0.01% 973
2020
Q2 		$109K Buy
974
+305
+46% +$32.4K 0.01% 965
2020
Q1 		$60.1K Buy
669
+209
+45% +$20.5K 0.01% 1091
2019
Q4 		$49.7K Buy
460
+140
+44% +$15K ﹤0.01% 1347
2019
Q3 		$31.3K Sell
320
-71
-18% -$8K ﹤0.01% 1481
2019
Q2 		$51.2K Buy
391
+6
+2% +$773 ﹤0.01% 1263
2019
Q1 		$52K Sell
385
-2
-0.5% -$249 ﹤0.01% 1177
2018
Q4 		$37.7K Buy
387
+17
+5% +$2.01K ﹤0.01% 1129
2018
Q3 		$51.4K Buy
370
+30
+9% +$3.76K 0.01% 1096
2018
Q2 		$42.2K Hold
340
– – 0.01% 1143
2018
Q1 		$37.9K Buy
340
+30
+10% +$3.59K 0.01% 1141
2017
Q4 		$37.1K Buy
+310
New +$37.8K 0.01% 1111

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

American Portfolios Advisors's ALXN Position: Q3 2021 in Review

American Portfolios Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 50 shares — an estimated $9.19K sold.

American Portfolios Advisors first reported a position in ALXN in Q4 2017 and held it in 15 quarters. The position peaked at $222K in Q1 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • American Portfolios Advisors reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • American Portfolios Advisors sold 50 Alexion Pharmaceuticals shares in Q3 2021, an estimated $9.19K.
  • American Portfolios Advisors first reported a position in Alexion Pharmaceuticals in Q4 2017 and held it in 15 quarters.
  • American Portfolios Advisors's Alexion Pharmaceuticals position peaked at $222K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on American Portfolios Advisors's 13F filing for Q3 2021, filed 22 Mar 2023.